APGE Q4 2025 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$400,000

Operating Income

-$78M

Net Income

$186M

EPS (Diluted)

$-1.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$63M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$937M

Total Liabilities

$33M

Stockholders' Equity

$904M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$400,000	$0	—
Operating Income	-$78M	-$76M	-2.9%
Net Income	$186M	-$67M	+377.4%